首页> 外文期刊>Journal of Young Pharmacists >Application of 32 Factorial D-Optimal Design in Formulation of Porous Osmotic Pump Tablets of Ropinirole; An Anti-Parkinson’s Agent
【24h】

Application of 32 Factorial D-Optimal Design in Formulation of Porous Osmotic Pump Tablets of Ropinirole; An Anti-Parkinson’s Agent

机译:32因子D-最优设计在罗匹尼罗多孔渗透泵片制剂中的应用反帕金森氏剂

获取原文
           

摘要

Objective : In the present study, our objective was to develop porous osmotic pump tablets of an anti-Parkinson’s agent, ropinirole. It also aimed to demonstrate the applicability of factorial designs and there by a statistical optimization in developing a controlled drug releasing device. Methods: A 32 factorial D-optimal study design was adopted to identify an optimized formulation. Tablets were prepared by direct compression using varying amounts of microcrystalline cellulose (MCC) and sodium chloride, followed by coating with semipermeable membrane of cellulose acetate (CA) containing polyethylene glycol (PEG) 400 as a pore former. The plasticity of the membranes was adjusted using castor oil. All the formulations were evaluated for various physical parameters including in vitro drug release and the effect of osmogent and pore former were also studied. Drug release kinetics studies such as zero order, first order and Korsmeyer Peppas were carried out and compared. ANOVA in drug release of all the formulations were determined. Formulations were optimized by using numerical optimization technique to achieve a controlled zero order release of ropinirole for 12 hours. Results : Drug release from the optimized formulation containing 20%w/w of PEG, without osmogent was not significantly affected by change in pH or agitation of the dissolution medium. The mechanism of drug release was further confirmed by studying the effect of osmotic pressure on drug release. Conclusion: The porous osmotic pump tablets of ropinirole can provide prolonged, controlled and GI environment-independent drug release. A software based optimization is helpful and reliable in developing porous osmotic pump tablets.
机译:目的:在本研究中,我们的目的是开发一种抗帕金森氏剂罗匹尼罗的多孔渗透泵片。它还旨在通过开发统计方法优化可控药物释放装置来证明析因设计的适用性。方法:采用3 2 阶乘D最优研究设计,确定最佳配方。通过使用不同量的微晶纤维素(MCC)和氯化钠直接压片来制备片剂,然后用包含聚乙二醇(PEG)400作为成孔剂的醋酸纤维素(CA)的半透膜包衣。使用蓖麻油调节膜的可塑性。评价所有制剂的各种物理参数,包括体外药物释放,还研究了渗透和成孔剂的作用。进行了药物释放动力学研究,如零级,一级和Korsmeyer Peppas。测定所有制剂的药物释放的方差分析。通过使用数值优化技术对制剂进行优化,以实现罗匹尼罗的零级受控释放12小时。结果:pH值的变化或溶解介质的搅动对含有20%w / w PEG(无渗透剂)的优化配方药物的释放没有显着影响。通过研究渗透压对药物释放的影响,进一步证实了药物释放的机制。结论:罗匹尼罗的多孔渗透泵片可提供延长的,可控的和胃肠道环境无关的药物释放。基于软件的优化在开发多孔渗透泵片剂方面是有用且可靠的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号